JP Morgan Put 130 PSX 16.01.2026/ DE000JK7KFC5 /
2024-06-19 11:23:00 AM | Chg.+0.04 | Bid10:00:39 PM | Ask10:00:39 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
2.22EUR | +1.83% | - Bid Size: - |
- Ask Size: - |
Phillips 66 | 130.00 USD | 2026-01-16 | Put |
GlobeNewswire
06-17
Phillips Edison & Company Inc. Invites You to Join Its Second Quarter 2024 Earnings Conference Call
GlobeNewswire
06-17
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
06-12
Greystone Closes $22.9 Million in Total Debt Placement and Preferred Equity Financing for Fort Worth...
GlobeNewswire
06-05
EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
05-29
Phillips Edison & Company to Present at Nareit REITweek 2024 Investor Conference
GlobeNewswire
05-22
Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention
GlobeNewswire
05-20
Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease We...
GlobeNewswire
05-16
Optimal Daily Dairy Consumption Remains Elusive Despite Well-Established Health Benefits
GlobeNewswire
05-16
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Newsfile Corp
05-15
King Fuels Announces Strategic Expansion of Its Fuel Distribution Network in Texas, Colorado, Kansas...
GlobeNewswire
05-14
Kontrolmatik Technologies and Pomega Standardize Operations With Siemens Solutions and Form an Engin...
GlobeNewswire
05-13
Safe Boating Campaign’s Annual National Safe Boating Week Celebrates All Boaters This May 18-24, 202...
GlobeNewswire
05-10
First Wave BioPharma, Inc. to raise approximately $1.1 million of Gross Proceeds Priced At-the-Marke...
GlobeNewswire
05-09
First Wave BioPharma and Celiac Journey to Host Nasdaq Event in Support of Celiac Disease Awareness ...